🔗 Permalink

Inventor profile of:

David Lewis

City:

Madison, Wisconsin

Country:

United States

Published Applications:

Last publication date:

2026-06-25

Top Assignees for applications by David Lewis

The entities that hold a legal rights for patent applications filed by inventor Lewis David:

EMPIRICO INC. 8 San Diego, CA United States
ARROWHEAD MADISON INC. 1 Madison, WI United States

Recent patent applications by Lewis David

David Lewis from Madison, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-25

US20260176623A1

Chemistry; metallurgy

PROCESS TO INHIBIT OR ELIMINATE EOSINOPHILIC DISEASES OF THE AIRWAY AND RELATED CONDITIONS

#2 | 2026-04-02

US20260091053A1

Human necessities

TREATMENT OF THYMIC STROMAL LYMPHOPOIETIN (TSLP) RELATED DISEASES BY INHIBITION OF LONG-FORM TSLP TRANSCRIPTS

#3 | 2026-02-26

US20260055410A1

Chemistry; metallurgy

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

#4 | 2025-10-30

US20250333732A1

Chemistry; metallurgy

TREATMENT OF SOS2 RELATED DISEASES AND DISORDERS

#5 | 2025-10-23

US20250327127A1

Chemistry; metallurgy

SMALL MOLECULE TREATMENT OF MTRES1 RELATED DISEASES AND DISORDERS

#6 | 2025-10-09

US20250313841A1

Chemistry; metallurgy

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

#7 | 2025-08-07

US20250250568A1

Chemistry; metallurgy

MODIFIED OLIGONUCLEOTIDES

#8 | 2025-07-17

US20250228883A1

Human necessities

Process to Inhibit or Eliminate Eosinophilic Diseases of the Airway and Related Conditions

#9 | 2025-06-19

US20250197859A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES

#10 | 2025-06-19

US20250195555A1

Human necessities

TREATMENT OF HGFAC RELATED DISEASES AND DISORDERS

#11 | 2025-03-20

US20250090559A1

Human necessities

PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME

#12 | 2025-02-06

US20250043281A1

Chemistry; metallurgy

TREATMENT OF FGG RELATED DISEASES AND DISORDERS

#13 | 2024-11-28

US20240392299A1

Chemistry; metallurgy

TREATMENT OF MST1R RELATED DISEASES AND DISORDERS

#14 | 2024-11-28

US20240392296A1

Chemistry; metallurgy

Treatment of MST1 related diseases and disorders

#15 | 2024-11-28

US20240392295A1

Chemistry; metallurgy

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

#16 | 2024-08-29

US20240287523A1

Chemistry; metallurgy

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

#17 | 2024-08-29

US20240287519A1

Chemistry; metallurgy

TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS

#18 | 2024-08-29

US20240287518A1

Chemistry; metallurgy

TREATMENT OF MTRES1 RELATED DISEASES AND DISORDERS

#19 | 2024-08-29

US20240287517A1

Chemistry; metallurgy

TREATMENT OF PLIN1 RELATED DISEASES AND DISORDERS

#20 | 2024-08-22

US20240279663A1

Chemistry; metallurgy

TREATMENT OF ANGPTL4 RELATED DISEASES

#21 | 2024-05-30

US20240175031A1

Chemistry; metallurgy

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

#22 | 2023-11-09

US20230357774A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES

#23 | 2023-09-28

US20230304008A1

Chemistry; metallurgy

Modified oligonucleotides

#24 | 2023-08-10

US20230248752A1

Human necessities

PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME

#25 | 2023-03-09

US20230074280A1

Human necessities

TREATMENT OF THYMIC STROMAL LYMPHOPOIETIN (TSLP) RELATED DISEASES BY INHIBITION OF LONG-FORM TSLP TRANSCRIPTS

#26 | 2022-10-27

US20220340907A1

Chemistry; metallurgy

OLIGONUCLEOTIDES FOR TREATMENT OF ANGIOPOIETIN LIKE 4 (ANGPTL4) RELATED DISEASES

#27 | 2022-02-24

US20220056444A1

Chemistry; metallurgy

PROCESS TO INHIBIT OR ELIMINATE EOSINOPHILIC DISEASES OF THE AIRWAY AND RELATED CONDITIONS

#28 | 2022-02-17

US20220047612A1

Human necessities

Prodrugs of ALOX-15 inhibitors and methods of using the same

#29 | 2022-02-10

US20220040220A1

Human necessities

Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts

#30 | 2022-01-06

US20220002731A1

Chemistry; metallurgy

Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseases

#31 | 2021-11-25

US20210361693A1

Human necessities

PROCESS TO INHIBIT OR ELIMINATE EOSINOPHILIC DISEASES OF THE AIRWAY AND RELATED CONDITIONS

#32 | 2021-06-03

US20210163950A1

Chemistry; metallurgy

TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES

#33 | 2021-02-04

US20210030772A1

Human necessities

Prodrugs of ALOX-15 inhibitors and methods of using the same

#34 | 2020-12-24

US20200399640A1

Chemistry; metallurgy

Treatment of angiopoietin like 7 (ANGPTL7) related diseases

#35 | 2013-07-25

US20130190484A1

Chemistry; metallurgy

In vivo polynucleotide delivery conjugates having enzyme sensitive linkages

InventorID:

355980 ⎘